OMX Nordic 40
2.342,71
PKT
-9,25
PKT
-0,39
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.07.25 | AstraZeneca Buy | UBS AG | |
| 14.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.07.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 11.07.25 | Novo Nordisk Buy | UBS AG | |
| 09.07.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 09.07.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09.07.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.07.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 08.07.25 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 04.07.25 | AstraZeneca Buy | UBS AG | |
| 04.07.25 | Volvo (B) Outperform | RBC Capital Markets | |
| 04.07.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 03.07.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.07.25 | Nokia Underweight | Barclays Capital | |
| 03.07.25 | Nokia Market-Perform | Bernstein Research | |
| 03.07.25 | Novo Nordisk Buy | UBS AG | |
| 02.07.25 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 02.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.07.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 01.07.25 | Novo Nordisk Buy | UBS AG | |
| 01.07.25 | AstraZeneca Buy | UBS AG | |
| 30.06.25 | Hennes Mauritz (H M, H&M) Equal Weight | Barclays Capital | |
| 30.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.06.25 | Novo Nordisk Buy | UBS AG | |
| 27.06.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 27.06.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 26.06.25 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 26.06.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 26.06.25 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 26.06.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 26.06.25 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 26.06.25 | AstraZeneca Outperform | Bernstein Research | |
| 25.06.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 25.06.25 | Volvo (B) Buy | UBS AG | |
| 24.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.06.25 | Volvo (B) Underperform | Bernstein Research | |
| 24.06.25 | Volvo (B) Buy | UBS AG | |
| 24.06.25 | Novo Nordisk Buy | UBS AG | |
| 24.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.06.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research |